On-Demand Webinar

Biosafety, Ethical, and Logistical Challenges to Pursuing a Coronavirus Vaccine at Warp Speed

The SARS-CoV-2 pandemic has impacted all aspects of society. Various government and private groups around the world are endeavoring to develop safe and effective vaccines at an unprecedented pace and scale to quell the pandemic as quickly as possible. In addition, the first COVID-19 vaccines approved leveraged novel messenger RNA (mRNA) technologies. With Advarra’s IRB and IBC experience in supporting 100% of Operation Warp Speed vaccine clinical trials, we have insight on the challenges faced while working in support of the goal to deliver safe and effective COVID-19 vaccines to the American public as quickly as possible.

In our upcoming webinar, Advarra experts Daniel Eisenman, Director of Biosafety Services, and Luke Gelinas, IRB Chair, share the biosafety, ethical, and logistical challenges faced throughout the research process of developing COVID-19 vaccines.

Learning Objectives:

  • Understand the vaccine development challenges posed by the pandemic
  • Learn how to perform risk assessments for genetically engineered COVID-19 vaccines
  • Discuss the ethical considerations
  • Evaluate status and challenges ahead, including second generation COVID-19 vaccine trials

Presented By

Dan Eisenman.png

Daniel Eisenman

PhD, RBP, SM(NRCM), CBSP

Director of Biosafety Services
Advarra

Luke Gelinas.png

Luke Gelinas

PhD

IRB Chair
Advarra

Shannon Roznoski.png

NA

NA
NA

Empty Image Placeholder

NA

NA

NA
NA

 

Who should watch?

This content applies to research professionals representing sponsors, CROs, institutions, and sites who are involved in research pertaining to infectious disease vaccines, oncology, immune therapy and gene therapy.

CE Credits

Attendance at this session has been approved for 1.00 contact hour of research specific continuing education on applications for Maintenance of ACRP’s CCRC®, CCRA®, CPI®, or ACRP-CP® certification designations.

This session meets the Certified IRB Professional (CIP) recertification guidelines for a maximum of 1 credit.

Provider approved by the California Board of Registered Nursing, Provider Number 16549, for 1 contact hour. This documentation must be retained by the licensee for a period of 4 years after the course concludes.

The Society of Clinical Research Associates (SOCRA - www.SOCRA.org) accepts documentation of candidate participation in continuing education programs for recertification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area. This program offers 1 hour of CE credit.

If you would like to obtain CE credits for a different credential, please check with your professional organization to determine if our webinars meet their continuing education requirements.

Certificate of Attendance

After watching this webinar in its entirety and completing the webinar survey, you will receive a certificate of attendance. This certificate will be emailed to you within one business day of watching the webinar. Please note that if your organization has other staff members who wish to get a certificate of attendance, each person must register, watch the webinar in its entirety, and complete the webinar survey. Visit our Webinar Help page for more information on certificates of attendance.

DATE: February 11, 2021
Time: 1 pm ET | 10 am PT
Duration: 1 hour

Register Now